Laurent Landais

BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical Pharmacology

Xavier Ligneau, David Perrin, Laurent Landais et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 233 citations

Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.

Antoine Bril, Bernard Gout, Marie-Chantal Bonhomme et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 109 citations

Brain histamine and schizophrenia: Potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649

Xavier Ligneau, Laurent Landais, David Perrin et al. · Biochemical Pharmacology · 2007 · 104 citations · Full text

Psychiatry, Potential Therapeutic Applications, Medicine +15

Actions and interactions of E-4031 and tedisamil on reperfusion-induced arrhythmias and QT interval in rat in vivo

Antoine Bril, Laurent Landais, Bernard Gout · Cardiovascular Drugs and Therapy · 1993 · 21 citations

Cardiac Muscle, Heart Failure, Cardiac Mechanic +11

Nonclinical cardiovascular safety of pitolisant: comparing International Conference on Harmonization S7B and Comprehensive <i>in vitro</i> Pro‐arrhythmia Assay initiative studies

Xavier Ligneau, Rashmi R. Shah, Isabelle Berrebi‐Bertrand et al. · British Journal of Pharmacology · 2017 · 16 citations · Full text